Ticker Scorecard - TIL Basics Company: Instil Bio, Inc. IPO Date: March 19, 2021 Sector: Healthcare Industry: Biotech Market Cap: $144.35M Activated in VL: True Average Daily Range Avg Daily Range: $0.59 | 4.06% Avg Daily Range (30 D): $1.29 | 5.86% Avg Daily Range (90 D): $1.53 | 5.75% Institutional Daily Volume Avg Daily Volume: .04M Avg Daily Volume (30 D): .08M Avg Daily Volume (90 D): .09M Trade Size Avg Trade Size (Sh.): 13 Avg Trade Size (Sh.) (30 D): 40 Avg Trade Size (Sh.) (90 D): 45 Institutional Trades Total Inst.Trades: 183 Avg Inst. Trade: $2.27M Avg Inst. Trade (30 D): $1.34M Avg Inst. Trade (90 D): $1.12M Avg Inst. Trade Volume: .01M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $6.5M Avg Closing Trade (30 D): $.61M Avg Closing Trade (90 D): $.61M Avg Closing Volume: 35.31K     News Jan 14, 2025 @ 12:00 PM Instil Bio Announces Clinical Progress in China fo... Source: N/A Oct 24, 2024 @ 9:13 AM Up Over 600% in 2024, Can Summit Therapeutics Stoc... Source: Cory Renauer Sep 17, 2024 @ 8:24 AM Here's Why Everyone's Talking About Summit Therape... Source: Cory Renauer Sep 16, 2024 @ 10:00 AM Instil Bio and ImmuneOnco Announce Global Registra... Source: N/A May 10, 2024 @ 11:00 AM Instil Bio Reports First Quarter 2024 Financial Re... Source: Instil Bio Financials   TTM Q3 2024 Q2 2024 Basic EPS $-11.56 $-3.54 $-2.29 Diluted EPS $-11.56 $-3.54 $-2.29 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -75.17M $ -23.02M $ -14.92M Operating Income / Loss $ -74.74M $ -23.63M $ -14.14M Cost of Revenue $ $ $ Net Cash Flow $ -3.48M $ -4.1M $ .01M PE Ratio     Splits Dec 08, 2023:   20:1